{"id":59711,"date":"2024-07-18T10:04:24","date_gmt":"2024-07-18T08:04:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/"},"modified":"2024-07-18T10:04:24","modified_gmt":"2024-07-18T08:04:24","slug":"ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/","title":{"rendered":"GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\nAgreement to acquire business adds innovative, real-time image recognition technology and expertise to GE HealthCare\u2019s portfolio of AI-enabled devices<\/li>\n<li>\nAI-based technology from Intelligent Ultrasound aims to provide real-time support for OBGYN scans and improve exam accuracy and efficiency<\/li>\n<li>\nPlanned acquisition supports GE HealthCare\u2019s precision care strategy to address inefficiencies and improve patient care quality<\/li>\n<\/ul>\n<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.intelligentultrasound.com%2F&amp;esheet=54095905&amp;newsitemid=20240717580041&amp;lan=en-US&amp;anchor=Intelligent+Ultrasound+Group+PLC%26%238217%3Bs&amp;index=1&amp;md5=94f2638a6e2012af338fc33fc1dca1b6\" rel=\"nofollow noopener\" shape=\"rect\">Intelligent Ultrasound Group PLC\u2019s<\/a> (Intelligent Ultrasound) clinical artificial intelligence (AI) software business for total consideration of approximately $51 million. Intelligent Ultrasound is a leader in integrated AI-driven image analysis tools designed to make ultrasound smarter and more efficient. GE HealthCare plans to incorporate these solutions across the ultrasound portfolio, strengthening its capabilities with technology that helps improve workflows and enhance ease-of-use for the benefit of clinicians and patients.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240717580041\/en\/1907724\/5\/GE_HealthCare_logo_NEW_March_2023.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240717580041\/en\/1907724\/22\/GE_HealthCare_logo_NEW_March_2023.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240717580041\/en\/1907724\/5\/GE_HealthCare_logo_NEW_March_2023.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240717580041\/en\/1907724\/21\/GE_HealthCare_logo_NEW_March_2023.jpg\"><\/a><\/p>\n<p>\n&#8220;We are pleased to bring innovative technology from Intelligent Ultrasound into GE HealthCare\u2019s Ultrasound portfolio, allowing us to fully integrate these solutions into our systems to help clinicians improve workflow, reduce repetitive tasks, and simplify exams,\u201d said Phil Rackliffe, president and CEO of Ultrasound and Image Guided Therapies, GE HealthCare. \u201cThis technology and the experts who developed it will help enhance our portfolio of AI-enabled devices and accelerate our pace of development of next-generation AI tools.\u201d<\/p>\n<p>\nIntelligent Ultrasound has pioneered the ScanNav Assist AI technology, which powers SonoLyst<i>live<\/i> and SonoLyst X\/IR, available on GE HealthCare\u2019s Voluson\u2122 Expert and Voluson Signature ultrasound devices. SonoLyst is also currently available on the Voluson SWIFT. By acquiring this business, GE HealthCare also adds an AI innovation pipeline that serves to help advance future development and realize long-term efficiencies.<\/p>\n<p>\nGE HealthCare plans to welcome the team of research and development experts from Intelligent Ultrasound, who will help drive AI-enabled image recognition and innovation for GE HealthCare Women\u2019s Health ultrasound devices as well as across the broader portfolio. This agreement follows GE HealthCare\u2019s acquisition of Caption Health in 2023, which added new capabilities in AI-enabled image guidance and AI development expertise to aid in early disease detection in other areas.<\/p>\n<p>\n\u201cI really believe that we are at the start of a wave of AI making a profound difference to medical imaging, and especially ultrasound,\u201d said Nick Sleep, Chief Operating Officer, Intelligent Ultrasound, who will join GE HealthCare. \u201cBecoming part of the GE HealthCare family will help speed the adoption of this technology and make ultrasound even easier for customers to use.\u201d<\/p>\n<p>\nThese technologies are especially vital to relieving burdens placed on sonographers. As exams are becoming more complex, 81 percent of hospitals report radiology technologist shortages,<sup>1<\/sup> and 90 percent of sonographers report work-related musculoskeletal disorders due to workload and repetitive motions, among other factors.<sup>2<\/sup> Streamlined workflows and AI-enabled protocols can reduce manual processes, provide greater reproducibility between users, and allow clinicians to focus more on patient care.<\/p>\n<p>\nThis agreement bolsters <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gehealthcare.com%2Fabout%2Fnewsroom%2Fpress-releases%2Fge-healthcare-tops-list-for-third-year-in-a-row-with-highest-number-of-ai-enabled-medical-device-authorizations&amp;esheet=54095905&amp;newsitemid=20240717580041&amp;lan=en-US&amp;anchor=GE+HealthCare%26%238217%3Bs+portfolio+of+AI-enabled+devices&amp;index=2&amp;md5=ea2cdff37fceb99a37c0172acaf5474a\" rel=\"nofollow noopener\" shape=\"rect\">GE HealthCare\u2019s portfolio of AI-enabled devices<\/a>\u2014 which presently tops the FDA\u2019s list of AI-enabled device authorizations across medical technology companies\u2014and supports the Company\u2019s precision care strategy to solve for inefficiencies in the clinical care workflow and improve patient care quality across the care pathway. With the sale of its clinical AI business, Intelligent Ultrasound will continue to operate with a renewed focus on its world-class, high-fidelity ultrasound simulation technology designed to enhance ultrasound education.<\/p>\n<p>\nThe consummation of the transaction is subject to customary closing conditions and is expected to close in Q4 2024. Additional details of the transaction have not been disclosed publicly. GE HealthCare intends to fund this transaction with cash on hand.<\/p>\n<p>\n<b>Forward-Looking Statements<\/b><\/p>\n<p>\nThis release contains forward-looking statements. These forward-looking statements might be identified by words, and variations of words, such as \u201cwill,\u201d \u201cexpect,\u201d \u201cmay,\u201d \u201cwould,\u201d \u201ccould,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cestimate,\u201d \u201cpotential,\u201d \u201cposition,\u201d \u201cforecast,\u201d \u201ctarget,\u201d \u201cguidance,\u201d \u201coutlook,\u201d and similar expressions. These forward-looking statements may include, but are not limited to, statements about the transaction, the completion and expected results of the transaction, and GE HealthCare Technologies Inc.\u2019s (the \u201cCompany\u2019s\u201d) performance, growth opportunities, and strategy. These forward-looking statements involve risks and uncertainties, many of which are beyond the control of the Company. Factors that could cause the Company\u2019s actual results to differ materially from those described in its forward-looking statements include, but are not limited to, the conditions to the completion of the transaction may not be satisfied; closing of the transaction may not occur or may be delayed; the Company may be unable to achieve the anticipated benefits of the transaction; operating costs and business disruptions (including, without limitation, difficulties in maintaining relationships with employees, customers, and suppliers) may be greater than expected; the Company may assume unexpected risks and liabilities; and completing the transaction may distract the Company\u2019s management from other important matters. Other factors that may cause such a difference also include those discussed in the &#8220;Risk Factors&#8221; section of the Company\u2019s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission and any updates or amendments it makes in future filings. There may be other factors not presently known to the Company or which it currently considers to be immaterial that could cause the Company\u2019s actual results to differ materially from those projected in any forward-looking statements the Company makes. The Company does not undertake any obligation to update or revise its forward-looking statements except as required by applicable law or regulation.<\/p>\n<p>\n<b>About GE HealthCare Technologies Inc.<\/b><\/p>\n<p>\nGE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient\u2019s journey across the care pathway. Together our Imaging, Ultrasound and Image Guided Therapies, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.<\/p>\n<p>\nFollow us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fgehealthcare&amp;esheet=54095905&amp;newsitemid=20240717580041&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=3&amp;md5=1cbcd26697ab113029f64ead23cfd911\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>, <a target=\"_blank\" href=\"https:\/\/x.com\/GEHealthCare\" id=\"smartlink3\" rel=\"nofollow noopener\" shape=\"rect\">X<\/a> , <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.facebook.com%252FGEHealthCare%252F%26data%3D05%257C02%257CKyerstin.Barry%2540gehealthcare.com%257Cb701f0ff77664e18215f08dc58c25e46%257C9a309606d6ec4188a28a298812b4bbbf%257C0%257C0%257C638482839023721954%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C0%257C%257C%257C%26sdata%3DCbmOy6gyy6H8i4L%252Bt29ZhPEBbxsyxeKEsEGm6Uoetn4%253D%26reserved%3D0&amp;esheet=54095905&amp;newsitemid=20240717580041&amp;lan=en-US&amp;anchor=Facebook&amp;index=4&amp;md5=4878c1730f8dd1bc95cb29e948fec4bd\" rel=\"nofollow noopener\" shape=\"rect\">Facebook<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam10.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.instagram.com%252Fgehealthcare%26data%3D05%257C02%257CKyerstin.Barry%2540gehealthcare.com%257Cb701f0ff77664e18215f08dc58c25e46%257C9a309606d6ec4188a28a298812b4bbbf%257C0%257C0%257C638482839023726667%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C0%257C%257C%257C%26sdata%3DHYszANA8gtV355HYFjpfXsTuS4ddh8HlqdLu6u4A4To%253D%26reserved%3D0&amp;esheet=54095905&amp;newsitemid=20240717580041&amp;lan=en-US&amp;anchor=Instagram&amp;index=5&amp;md5=dd16e50540436231b40b11b14debdd4f\" rel=\"nofollow noopener\" shape=\"rect\">Instagram<\/a>, and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gehealthcare.com%2Finsights%3FshowPopup%3Dfalse&amp;esheet=54095905&amp;newsitemid=20240717580041&amp;lan=en-US&amp;anchor=Insights&amp;index=6&amp;md5=9d413cd23293878e85cefd344ae07807\" rel=\"nofollow noopener\" shape=\"rect\">Insights<\/a> for the latest news, or visit our website <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gehealthcare.com%2F&amp;esheet=54095905&amp;newsitemid=20240717580041&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.gehealthcare.com%2F&amp;index=7&amp;md5=2c15e99539b7bed99afff213591579fb\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.gehealthcare.com\/<\/a> for more information.<\/p>\n<p>\n<b>About Intelligent Ultrasound Group<\/b><\/p>\n<p>\nIntelligent Ultrasound (AIM: IUG) is one of the world&#8217;s leading &#8216;classroom to clinic&#8217; ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market (&#8216;classroom&#8217;) and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market (&#8216;clinic&#8217;). Based in Cardiff in the UK and Atlanta in the US, the Group has two revenue streams:<\/p>\n<p>\n<span class=\"bwuline\">Simulation<\/span><\/p>\n<p>\nReal-time hi-fidelity ultrasound education and training through simulation. Our main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid-19 module and the new BabyWorks Neonate and Paediatric training simulator. To date over 1,500 simulators have been sold to over 750 medical institutions around the world.<\/p>\n<p>\n<span class=\"bwuline\">Clinical AI software<\/span><\/p>\n<p>\nDeep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE HealthCare&#8217;s SonoLyst software that is incorporated in their Voluson Expert 22 and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB.<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.intelligentultrasound.com&amp;esheet=54095905&amp;newsitemid=20240717580041&amp;lan=en-US&amp;anchor=www.intelligentultrasound.com&amp;index=8&amp;md5=5d54d853c4020c775b60cda07c3c5a3a\" rel=\"nofollow noopener\" shape=\"rect\">www.intelligentultrasound.com<\/a><\/p>\n<p>\n<sup>1<\/sup> \u201cRadiology Staffing Shortages Nation Wide?\u201d, AHEC online, Sept 27, 2021.<\/p>\n<p>\n<sup>2<\/sup> Work Related Musculoskeletal Disorders in Sonography, Society of Diagnostic Medical Sonography, Susan Murphey, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sdms.org%2Fdocs%2Fdefault-source%2FResources%2Fwork-related-musculoskeletal-disorders-in-sonography-white-paper.pdf%3Fsfvrsn%3D10&amp;esheet=54095905&amp;newsitemid=20240717580041&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.sdms.org%2Fdocs%2Fdefault-source%2FResources%2Fwork-related-musculoskeletal-disorders-in-sonography-white-paper.pdf%3Fsfvrsn%3D10&amp;index=9&amp;md5=7747874050094ead27f64bd3a5981916\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.sdms.org\/docs\/default-source\/Resources\/work-related-musculoskeletal-disorders-in-sonography-white-paper.pdf?sfvrsn=10<\/a><\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>GE HealthCare Media Contact<\/b><br \/>Eric Tatro<br \/>\n<br \/>GE HealthCare<br \/>\n<br \/>+1 312 459 6140<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#69;r&#x69;&#x63;&#46;&#x54;&#x61;&#116;r&#x6f;&#64;g&#x65;&#104;e&#x61;&#x6c;&#116;&#x68;&#x63;&#97;r&#x65;&#46;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">E&#114;&#105;&#x63;&#x2e;Ta&#116;&#114;&#x6f;&#x40;ge&#104;&#101;&#x61;&#x6c;th&#99;&#x61;&#x72;&#x65;&#46;&#99;&#111;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Agreement to acquire business adds innovative, real-time image recognition technology and expertise to GE HealthCare\u2019s portfolio of AI-enabled devices AI-based technology from Intelligent Ultrasound aims to provide real-time support for OBGYN scans and improve exam accuracy and efficiency Planned acquisition supports GE HealthCare\u2019s precision care strategy to address inefficiencies and improve patient care quality CHICAGO&#8211;(BUSINESS &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59711","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Agreement to acquire business adds innovative, real-time image recognition technology and expertise to GE HealthCare\u2019s portfolio of AI-enabled devices AI-based technology from Intelligent Ultrasound aims to provide real-time support for OBGYN scans and improve exam accuracy and efficiency Planned acquisition supports GE HealthCare\u2019s precision care strategy to address inefficiencies and improve patient care quality CHICAGO&#8211;(BUSINESS ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-18T08:04:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240717580041\/en\/1907724\/22\/GE_HealthCare_logo_NEW_March_2023.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound\",\"datePublished\":\"2024-07-18T08:04:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\\\/\"},\"wordCount\":1305,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240717580041\\\/en\\\/1907724\\\/22\\\/GE_HealthCare_logo_NEW_March_2023.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\\\/\",\"name\":\"GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240717580041\\\/en\\\/1907724\\\/22\\\/GE_HealthCare_logo_NEW_March_2023.jpg\",\"datePublished\":\"2024-07-18T08:04:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240717580041\\\/en\\\/1907724\\\/22\\\/GE_HealthCare_logo_NEW_March_2023.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240717580041\\\/en\\\/1907724\\\/22\\\/GE_HealthCare_logo_NEW_March_2023.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/","og_locale":"en_US","og_type":"article","og_title":"GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound - Pharma Trend","og_description":"Agreement to acquire business adds innovative, real-time image recognition technology and expertise to GE HealthCare\u2019s portfolio of AI-enabled devices AI-based technology from Intelligent Ultrasound aims to provide real-time support for OBGYN scans and improve exam accuracy and efficiency Planned acquisition supports GE HealthCare\u2019s precision care strategy to address inefficiencies and improve patient care quality CHICAGO&#8211;(BUSINESS ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/","og_site_name":"Pharma Trend","article_published_time":"2024-07-18T08:04:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240717580041\/en\/1907724\/22\/GE_HealthCare_logo_NEW_March_2023.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound","datePublished":"2024-07-18T08:04:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/"},"wordCount":1305,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240717580041\/en\/1907724\/22\/GE_HealthCare_logo_NEW_March_2023.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/","url":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/","name":"GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240717580041\/en\/1907724\/22\/GE_HealthCare_logo_NEW_March_2023.jpg","datePublished":"2024-07-18T08:04:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240717580041\/en\/1907724\/22\/GE_HealthCare_logo_NEW_March_2023.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240717580041\/en\/1907724\/22\/GE_HealthCare_logo_NEW_March_2023.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-agreement-to-acquire-clinical-artificial-intelligence-business-from-intelligent-ultrasound\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"GE HealthCare announces agreement to acquire clinical artificial intelligence business from Intelligent Ultrasound"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59711"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59711\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}